Middle East News Watch
SEE OTHER BRANDS

The latest news from the Middle East

Middle East News Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.

Press releases published on April 16, 2025

Hub Cyber Security Appoints Shlomo Bibas as an Independent Member of the Board of Directors

Hub Cyber Security Appoints Shlomo Bibas as an Independent Member of the Board of Directors

TEL AVIV, Israel, April 16, 2025 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and advanced data fabric technology, is pleased to announce the appointment of Shlomo Bibas as …

Sabin Begins Marburg Vaccine Trial in U.S.

Sabin Begins Marburg Vaccine Trial in U.S.

WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in Melbourne, Florida. This trial …

Pillar Security Raises $9M to Help Enterprises Build and Run Secure AI Software

Pillar Security Raises $9M to Help Enterprises Build and Run Secure AI Software

TEL AVIV, Israel, April 16, 2025 (GLOBE NEWSWIRE) -- Today, Pillar Security, a pioneering AI security startup that helps enterprises build and run secure AI software, announced it has raised $9 million in Seed funding. The round was led by Shield Capital, …

Oncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023 

Oncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023 

AGOURA HILLS, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a developer of treatments for rare and orphan indications, including Parkinson's Disease, pancreatic ductal …

Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism

Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism

Vancouver, Canada, April 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference

GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference

LA JOLLA, CA, April 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …

Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit

Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit

MIAMI, FL, April 16, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that the …

SaverOne Signs New Distribution Agreement in Canada

SaverOne Signs New Distribution Agreement in Canada

SaverOne enters the Canadian market with a distribution agreement with MRF Geosystems with a 1,000-unit sales target for the first 6 months Petah Tikvah, Israel, April 16, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology …

Hepsiburada to Announce Fourth Quarter and Full Year 2024 Results on April 30, 2025

Hepsiburada to Announce Fourth Quarter and Full Year 2024 Results on April 30, 2025

ISTANBUL, Türkiye, April 16, 2025 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services …

Taking Anger Seriously: A Divine Answer for Human Anger, Presented by Atticus Publishing

Taking Anger Seriously: A Divine Answer for Human Anger, Presented by Atticus Publishing

‘Transforming Lives Through Divine Counsel’ SAN FRANCISCO , CA, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Atticus Publishing proudly presents "Taking Anger Seriously: A Divine Answer for Human Anger" by George Quin, a groundbreaking book aimed …

MCT Technic to present sustainable NOx solutions at Automec 2025

MCT Technic to present sustainable NOx solutions at Automec 2025

SÃO PAULO , April 16, 2025 (GLOBE NEWSWIRE) -- Türkiye-based technology company MCT Technic is set to showcase its environmentally conscious solutions at Automec 2025, taking place from April 22–26 at the São Paulo Expo. At Booth #J09, MCT Technic will …

MCT Technic apresentará soluções sustentáveis de NOx na Automec 2025

MCT Technic apresentará soluções sustentáveis de NOx na Automec 2025

SÃO PAULO , April 16, 2025 (GLOBE NEWSWIRE) -- A empresa de tecnologia MCT Technic, sediada na Turquia, está pronta para apresentar suas soluções ambientalmente conscientes na Automec 2025, que acontece de 22 a 26 de abril no São Paulo Expo. No estande # …

PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting

PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting

PRINCETON, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …

Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference

Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference

BOTHELL, Wash., April 16, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that Sam Lee, President and co-CEO, will present a Company overview at the Life Science Innovation Northwest (LSINW) 2025 Conference on Wednesday, April 23, …

Vaxartto Present at World Vaccine Congress Washington 2025 on April 23

Vaxartto Present at World Vaccine Congress Washington 2025 on April 23

SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will present at the World Vaccine …

Terra Balcanica Announces LIFE Offering

Terra Balcanica Announces LIFE Offering

Vancouver, British Columbia, April 16, 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1) is pleased to announce that it intends to complete a non-brokered, listed issuer financing exemption private …

HPQ Silicon and Novacium Sign MOU with GLD Alloys to produce Green Hydrogen with METAGENE™

HPQ Silicon and Novacium Sign MOU with GLD Alloys to produce Green Hydrogen with METAGENE™

MONTREAL, April 16, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in green engineering processes, is re-issuing an amended version of its April 10th, 2025, press …

HPQ Silicium et Novacium signent un protocole d’entente (MOU) avec GLD Alloys pour produire de l’hydrogène vert avec METAGENE™

HPQ Silicium et Novacium signent un protocole d’entente (MOU) avec GLD Alloys pour produire de l’hydrogène vert avec METAGENE™

MONTRÉAL, 16 avr. 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’ingénierie verte des procédés réédite une version modifiée de son communiqué du …

Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025

Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025

SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial results for the first quarter 2025 before …

Avicanna Announces Revocation of Management Cease Trade Order

Avicanna Announces Revocation of Management Cease Trade Order

TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service